Read + Share
Tate S, Nishikimi K, Matsuoka A, Otsuka S, et al. Bevacizumab-based Salvage Chemotherapy Improves Survival Outcomes for Patients
With Brain Metastasis from Ovarian Cancer. Anticancer Res 2022;42:2637-2644.
PMID: 35489752
|
 |
|
Tate S, Nishikimi K, Matsuoka A, Otsuka S, et al. Bevacizumab-based Salvage Chemotherapy Improves Survival Outcomes for Patients
With Brain Metastasis from Ovarian Cancer. Anticancer Res 2022;42:2637-2644.
PMID: 35489752
|
|
|
|